Insulet Corporation to Present at Upcoming Investor Conferences


BILLERICA, MA--(Marketwired - Feb 28, 2015) - Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced that management will present at the following upcoming investor conferences:

  • The Raymond James 36th Annual Institutional Investors Conference in Orlando, FL on Monday, March 2, 2015 at 4:00 p.m. EST. 

  • The Cowen and Company 35th Annual Health Care Conference in Boston, MA on Wednesday, March 4, 2015 at 10:00 a.m. EST.

To listen to a live audio webcast of the presentations, please visit http://investors.insulet.com/. A replay of each webcast will be available following the event.

During the presentations, material information concerning the Company, its operations, strategies and prospects may be discussed.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion. Insulet's subsidiary, Neighborhood Diabetes, is a leading distributor of diabetes products and supplies, delivered through a high touch customer service model. To read inspiring stories of people with diabetes living their lives to the fullest with OmniPod, visit our customer blog, Suite D: http://suited.myomnipod.com. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information, please visit: http://www.myomnipod.com.

Contact Information:

Investor Relations and Media Contact:

Deborah R. Gordon
Vice President, Investor Relations and Corporate Communications
(978) 600-7717
dgordon@insulet.com or ir@insulet.com